Orville
Back to product list
Elcar 1

Elcar

Composition: Levocarnitine

Form: Solution for intravenous and intramuscular injection

Indications: Acute hypoxic conditions (stroke, TIA), traumatic brain injury (TBI), circulatory encephalopathy, toxic brain damage, post-surgery recovery, carnitine deficiency, cardiomyopathy, coronary artery disease, post-infarction conditions, cardiogenic shock.

Contraindications: Individual intolerance, pregnancy, lactation (no safety data), childhood.

Dosage: Usually 0.5–1 g (1–2 ampoules) IV or IM daily for 3–7 days. In acute cerebrovascular accident — 1 g/day for 3 days, then 0.5 g/day for 7 days. For hemodialysis — 2 g after the procedure. For infarction/shock — 3–5 g/day (6–10 ampoules).

Side effects: Allergic reactions, muscle weakness (in uremia), vein pain with rapid injection.

Interactions: Glucocorticoids enhance tissue accumulation (except in the liver), anabolic steroids enhance the effect.

Warnings: Prescribed by a doctor. Rapid injection may cause vein irritation. Switching to oral form after injections is possible.

Age restrictions: From 18 years old

Pregnancy: Contraindicated during pregnancy and breastfeeding.

Country of origin: Russia

Manufacturer: PIK-PHARMA

Storage conditions: Store in a place protected from light at 15–25 °C. Keep out of reach of children.

Clinical studies:

L-Carnitine Injections in the Early Recovery Period of Ischemic Stroke

Doctor, 2018

Авторы: L. Chichanovskaya, O. Bahareva, K. Sorokina

Read

Where to buy:

FAQ:

In which cases is Elcar administered intravenously?

💬 For strokes, cerebral ischemia, cardiomyopathy, hypoxia, carnitine deficiency, and rehabilitation after trauma or surgeries.

Can Elcar be administered intramuscularly?

💬 Yes, it can be administered both intravenously and intramuscularly (depending on indications and patient's condition).